Cite

HARVARD Citation

    Wen, Y. et al. (2022). NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP. Gynecological endocrinology. pp. 1136-1146. [Online]. 
  
Back to record